William Fong

Partner, Hong Kong SAR



William Fong is a partner in the Mergers & Acquisitions and Private Equity Practice, based in Hong Kong.

William has over 10 years of experience advising private equity sponsors and their portfolio companies as well as public and private companies on domestic and cross-border acquisitions and divestitures.

Bars and Courts
Hong Kong
University of Hong Kong
University of Warwick


His experience* includes representing:

  • CAA China, a joint venture between CMC Capital and Creative Artists Agency, in its acquisition of leading Chinese sports agency Momentum Sports.
  • The Special Committee formed by the Board of Directors of Cellular Biomedicine Group, Inc. (Nasdaq: CBMG), a US-headquartered biopharmaceutical company engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases with operations in Greater China, on its going private sale to a consortium led by the CEO of CBMG, together with certain members of CBMG management, CBMG stockholders and financial sponsors.
  • CMC Capital Partners in multiple private equity transactions, acquisitions and divestitures in China involving a number of media and entertainment targets, including its investments in Yatsen Holding Limited and Fun Literature Limited.
  • EQT Partners and its portfolio company GPA Global, a leader in premium packaging, sustainable packaging and display solutions based in China, on GPA Global’s bolt-on acquisition of Hub Folding Box, a printing and packaging company in the US.
  • Goldman Sachs (Asia) LLC in multiple investments including in Cyclone Robotics, Shenzhen Tengyin Information Consulting, Puyi Biotechnology, Pulse Medical Imaging Technology, InferVision, 4Paradigm, LvYue and Klook.
  • Icon Group, a portfolio company of Goldman Sachs Principal Investment Area, in its acquisition of Hong Kong-based oncology clinic SunTech Medical Group.

*Includes experience prior to working in White & Case

Awards and Recognition

Recognized as a 'Rising Star' in China Business Law Journal 2022

Recognized as a 'Next Generation Partner' in Private Equity by Legal 500 Asia-Pacific 2021